Trastuzumab beyond progression: a cost-utility analysis

Matter-Walstra, K. W.; Dedes, K. J.; Schwenkglenks, M.; Brauchli, P.; Szucs, T. D.; Pestalozzi, B. C. (2010). Trastuzumab beyond progression: a cost-utility analysis. Annals of oncology, 21(11), pp. 2161-2168. Oxford University Press 10.1093/annonc/mdq250

[img]
Preview
Text
mdq250.pdf - Published Version
Available under License Publisher holds Copyright.

Download (345kB) | Preview

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology

ISSN:

0923-7534

Publisher:

Oxford University Press

Language:

English

Submitter:

Markus Müller

Date Deposited:

02 Oct 2018 08:56

Last Modified:

09 Apr 2024 15:06

Publisher DOI:

10.1093/annonc/mdq250

BORIS DOI:

10.7892/boris.116051

URI:

https://boris.unibe.ch/id/eprint/116051

Actions (login required)

Edit item Edit item
Provide Feedback